Like male
condoms, female condoms (FCs) provide protection against unintended pregnancy
and most sexually transmitted infections (STIs), including HIV. However, unlike
their male counterparts, female condoms remain a relatively unknown and
underfunded dual protection method. For a long time, the success of the product
has been affected by a combination of frequent stock-outs, skepticism, myths
and prejudices, high prices, and lack of variety.
In 2008, the
Universal Access to Female Condoms (UAFC) Joint Programme was formed by four organizations
(Netherlands Ministry of Foreign Affairs, I+solutions, Rutgers WPF and Oxfam
Novib) to address the bottlenecks around availability and access to female
condoms. As part of its holistic approach (combination of advocacy, large scale
female condom programming, and manufacturing support and regulatory issues),
UAFC commissioned a clinical study in China and South Africa to compare the functional
performance of and preferences for three new female condom designs (Cupid, Women’s
Condom and VA w.o.w.) compared to a ‘control’ design, called Female Condom 2
(FC2). In each country, around 300
people took part in the study who were primarily urban women aged 18-45 who
were either novice or experienced users of female condoms.
"The female condom is gaining ground as it should do, I myself used throughout my life six different methods for family planning and protection, not even counting abstinence, this shows that variety is key." Marijke Wijnroks, Director for Social Development / HIV and SRHR ambassador for the Netherlands
The primary
goal of the study was to look into the device functioning (clinical and
non-clinical breakage, total breakage, slippage, misdirection, and
invagination), while the study also looked into safety and acceptability. It
was found, both in China and South Africa, that most women preferred the Women’s Condom. Overall, the study concluded that the three new condoms are non-inferior
to the FCS, and recommended them as worthwhile products to add to the market
alongside the FC2 (report available here).
The data
gathered during this study will be used to secure regulatory approvals for the
female condoms, including UNFPA/WHO prequalification. The Cupid female condom,
as well as its manufacturer Cupid Ltd, was the first to fulfill all
requirements and was prequalified by UNFPA/WHO in July 2012, thereby
introducing more variety to the female
condom market.
At a recent
meeting in The Hague, The Netherlands, some experts spoke out in support of
this development as an important step in the right direction as variety of
designs will increase competition leading to lower prices for procurers and
eventually also for users, thus providing better access and more choice.
For more
information about the UAFC Joint Programme visit: www.condoms4all.org.
Download the full issue of the IPPF HIV Update newsletter: http://ippf.org/resource/HIV-Update-April
Download the full issue of the IPPF HIV Update newsletter: http://ippf.org/resource/HIV-Update-April